Dexcom executives, including Jeff Johnson, faced questioning from analysts like UBS and Raymond James regarding gross margins, international performance in markets like France and Japan, and resilience during a downturn.
1 report, 0 independent
Updated Jun 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Dexcom executives, including Jeff Johnson, faced questioning from analysts like UBS and Raymond James regarding gross margins, international performance in markets like France and Japan, and resilience during a downturn.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Dexcom
company that develops, manufactures and distributes continuous glucose monitoring systems
-
Jeff Johnson
researcher
Nothing else this week.
-
UBS
Swiss multinational investment bank and financial services company
-
Raymond James
Montreux Jazz Festival person ID 7418; keyboardist for Crosby, Stills & Nash
Coverage
Newest first; wire copies grouped- Unknown outlet